Park Ha Biological Technology is trading 5.7% down now at $2.38, with the reason for the October 12 decline unconfirmed. - No confirmed company-specific announcement explaining the move was identified; the company’s release page shows no announcement dated October 9–12. - An earlier offering is prior context, not an established catalyst. - Broader markets were mixed, while available reporting describes thin trading conditions.